Astrin Biosciences
Saint Paul, US · Founded 2020 · Delaware corporation
Founders & leadership
JP
JAYANT PARTHASARATHYNamed on SEC filing
RH
ROBBIE HORWITZNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$22.9M disclosed across 1 round · 2024
▶$22.9MraisedJun 2024 · 21 investors · BiotechnologyRule 506(b)
▶$22.9MraisedJun 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAYANT PARTHASARATHYExecutive Officer, Director
- ROBBIE HORWITZDirector
- Offering amount
- $22.9M
- Amount sold
- $22.9M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Astrin Biosciences raised?
- Astrin Biosciences has disclosed $22.9M raised across 1 round.
- Where is Astrin Biosciences headquartered?
- Astrin Biosciences is headquartered in Saint Paul, US.